• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶栓治疗期间全身循环和凝块溶解动力学的计算机模拟,该模拟考虑了凝块内部的运输和反应。

Computer simulation of systemic circulation and clot lysis dynamics during thrombolytic therapy that accounts for inner clot transport and reaction.

作者信息

Anand S, Diamond S L

机构信息

Department of Chemical Engineering, State University of New York at Buffalo 14260, USA.

出版信息

Circulation. 1996 Aug 15;94(4):763-74. doi: 10.1161/01.cir.94.4.763.

DOI:10.1161/01.cir.94.4.763
PMID:8772700
Abstract

BACKGROUND

We developed a computer model to predict lysis rates of thrombi for intravenous thrombolytic regimens based on the convective/diffusive penetration of reacting and adsorbing fibrinolytic species from the circulation into the proximal face of a dissolving clot.

METHODS AND RESULTS

Solution of a one-compartment plasma model provided the dynamic concentrations of fibrinolytic species that served as inlet conditions for stimulation of the one-dimensional spatiodynamics within a dissolving fibrin clot of defined composition. The model predicted the circulating levels of tissue plasminogen activator (TPA) and plasminogen levels found in clinical trials for various intravenous therapies. To test the model predictions under in vitro conditions, plasma clots were perfused with TPA (0.1 mumol/L) and plasminogen (1.0 mumol/L) delivered at constant permeation velocity of 0.1 or 0.2 mm/min. The model provided an accurate prediction of the measured lysis front movement. For TPA administration regimens used clinically, simulations predicted clot dissolution rates that were consistent with observed reperfusion times. For unidirectional permeation, the continual accumulation of adsorbing species at the moving lysis front due to prior rounds of solubilization and rebinding was predicted to provide for a marked concentration of TPA and plasmin and the eventual depletion of antiplasmin and macroglobulin in an advancing (approximately 0.25 mm thick) lysis zone.

CONCLUSIONS

Pressure-driven permeation greatly enhances and is a primary determinant of the overall rate of clot lysis and creates a complex local reaction environment at the plasma/clot interface. With simulation of reaction and transport, it becomes possible to quantitatively link the administration regimen, plasminogena activator properties, and thrombolytic outcome.

摘要

背景

我们开发了一种计算机模型,用于根据反应性和吸附性纤溶物质从循环系统向正在溶解的血栓近端表面的对流/扩散渗透,预测静脉溶栓方案中血栓的溶解速率。

方法与结果

单室血浆模型的解提供了纤溶物质的动态浓度,这些浓度作为刺激具有特定组成的溶解纤维蛋白凝块内一维空间动力学的入口条件。该模型预测了各种静脉治疗临床试验中发现的组织纤溶酶原激活剂(TPA)的循环水平和纤溶酶原水平。为了在体外条件下测试模型预测,以0.1或0.2 mm/min的恒定渗透速度灌注含有TPA(0.1 μmol/L)和纤溶酶原(1.0 μmol/L)的血浆凝块。该模型准确预测了测量的溶解前沿移动。对于临床使用的TPA给药方案,模拟预测的血栓溶解速率与观察到的再灌注时间一致。对于单向渗透,由于先前几轮的溶解和重新结合,预计在移动的溶解前沿吸附物质会持续积累,从而在前进的(约0.25 mm厚)溶解区内使TPA和纤溶酶显著浓缩,并最终消耗抗纤溶酶和巨球蛋白。

结论

压力驱动的渗透极大地增强了血栓溶解的总体速率,并且是其主要决定因素,同时在血浆/凝块界面处形成了复杂的局部反应环境。通过反应和传输模拟,可以定量地将给药方案、纤溶酶原激活剂特性和溶栓结果联系起来。

相似文献

1
Computer simulation of systemic circulation and clot lysis dynamics during thrombolytic therapy that accounts for inner clot transport and reaction.溶栓治疗期间全身循环和凝块溶解动力学的计算机模拟,该模拟考虑了凝块内部的运输和反应。
Circulation. 1996 Aug 15;94(4):763-74. doi: 10.1161/01.cir.94.4.763.
2
Inner clot diffusion and permeation during fibrinolysis.纤维蛋白溶解过程中的内部凝块扩散与渗透。
Biophys J. 1993 Dec;65(6):2622-43. doi: 10.1016/S0006-3495(93)81314-6.
3
Transport phenomena and clot dissolving therapy: an experimental investigation of diffusion-controlled and permeation-enhanced fibrinolysis.传输现象与血栓溶解疗法:扩散控制和渗透增强纤维蛋白溶解的实验研究
Thromb Haemost. 1994 Jul;72(1):105-12.
4
An experimental and theoretical study on the dissolution of mural fibrin clots by tissue-type plasminogen activator.组织型纤溶酶原激活剂溶解壁内纤维蛋白凝块的实验与理论研究
Biotechnol Bioeng. 2002 Feb 15;77(4):405-19.
5
Enzyme-mediated proteolysis of fibrous biopolymers: Dissolution front movement in fibrin or collagen under conditions of diffusive or convective transport.酶介导的纤维状生物聚合物的蛋白水解作用:在扩散或对流运输条件下纤维蛋白或胶原蛋白中的溶解前沿移动。
Biotechnol Bioeng. 1995 Oct 20;48(2):89-107. doi: 10.1002/bit.260480203.
6
Co-ordinated spatial propagation of blood plasma clotting and fibrinolytic fronts.血浆凝血和纤维蛋白溶解前沿的协调空间传播。
PLoS One. 2017 Jul 7;12(7):e0180668. doi: 10.1371/journal.pone.0180668. eCollection 2017.
7
In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.体外凝块溶解作为血栓对纤维蛋白溶解抵抗的潜在指标——在健康受试者中的研究及其与血液纤溶参数的相关性
Thromb Haemost. 1997 Apr;77(4):725-9.
8
Mechanisms by which thrombolytic therapy results in nonuniform lysis and residual thrombus after reperfusion.溶栓治疗在再灌注后导致溶解不均匀和残余血栓形成的机制。
Ann Biomed Eng. 1997 Nov-Dec;25(6):964-74.
9
Comparison of intrathecally administered urokinase, tissue-type plasminogen activator, and combination of urokinase and lysine-plasminogen for clot lysis after experimental subarachnoid hemorrhage in dogs.犬实验性蛛网膜下腔出血后鞘内注射尿激酶、组织型纤溶酶原激活剂以及尿激酶与赖氨酸纤溶酶原联合用药对血凝块溶解作用的比较。
Neurosurgery. 1997 Mar;40(3):572-7. doi: 10.1097/00006123-199703000-00029.
10
New developments in thrombolytic therapy.溶栓治疗的新进展。
Adv Exp Med Biol. 1990;281:333-54.

引用本文的文献

1
Blood clot contraction: Mechanisms, pathophysiology, and disease.血凝块收缩:机制、病理生理学与疾病
Res Pract Thromb Haemost. 2022 Dec 23;7(1):100023. doi: 10.1016/j.rpth.2022.100023. eCollection 2023 Jan.
2
The Utility and Potential of Mathematical Models in Predicting Fibrinolytic Outcomes.数学模型在预测纤溶结果中的效用与潜力
Curr Opin Biomed Eng. 2021 Dec;20. doi: 10.1016/j.cobme.2021.100337. Epub 2021 Sep 11.
3
Redistribution of TPA Fluxes in the Presence of PAI-1 Regulates Spatial Thrombolysis.PAI-1 存在时 TPA 通量的再分配调节空间溶栓。
Biophys J. 2020 Aug 4;119(3):638-651. doi: 10.1016/j.bpj.2020.06.020. Epub 2020 Jun 26.
4
Mathematical Modelling of Intravenous Thrombolysis in Acute Ischaemic stroke: Effects of Dose Regimens on Levels of Fibrinolytic Proteins and Clot Lysis Time.急性缺血性卒中静脉溶栓的数学建模:剂量方案对纤溶蛋白水平和血栓溶解时间的影响
Pharmaceutics. 2019 Mar 7;11(3):111. doi: 10.3390/pharmaceutics11030111.
5
Computational Simulations of Thrombolytic Therapy in Acute Ischaemic Stroke.急性缺血性脑卒中溶栓治疗的计算模拟。
Sci Rep. 2018 Oct 25;8(1):15810. doi: 10.1038/s41598-018-34082-7.
6
Systems Analysis of Thrombus Formation.血栓形成的系统分析
Circ Res. 2016 Apr 29;118(9):1348-62. doi: 10.1161/CIRCRESAHA.115.306824.
7
Towards a multi-physics modelling framework for thrombolysis under the influence of blood flow.迈向血流影响下溶栓的多物理场建模框架。
J R Soc Interface. 2015 Dec 6;12(113):20150949. doi: 10.1098/rsif.2015.0949.
8
Systems biology of coagulation.凝血系统生物学。
J Thromb Haemost. 2013 Jun;11 Suppl 1(0 1):224-32. doi: 10.1111/jth.12220.
9
Arrhenius temperature dependence of in vitro tissue plasminogen activator thrombolysis.体外组织型纤溶酶原激活剂溶栓的阿仑尼乌斯温度依赖性
Phys Med Biol. 2007 Jun 7;52(11):2953-67. doi: 10.1088/0031-9155/52/11/002. Epub 2007 May 2.
10
Development of an in vitro model to study clot lysis activity of thrombolytic drugs.用于研究溶栓药物凝块溶解活性的体外模型的开发。
Thromb J. 2006 Sep 12;4:14. doi: 10.1186/1477-9560-4-14.